Important note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
 |
New Vision (Kampala) - October 1, 2008
Francis Kagolo
"We are not yet able to adequately care for all people living with HIV/AIDS and provide them with anti-retroviral therapy. It is better for us to step up HIV prevention strategies," he said.
Ssekandi was recently speaking at the 17th annual general meeting of The Aids Support Organisation (TASO).
The meeting, held at the Uganda Manufacturers' Association main show ground at Lugogo in Kampala, attracted over 1,000 members.
Last year, over 312,000 people needed anti-retroviral therapy yet the nation could provide drugs for only 120,000 people, Ssekandi said.
"The national figures of the infected people are worrying. We should rejuvenate and sustain our efforts in the fight against HIV/AIDS."
Ssekandi said about 25,000 children are born with the virus every year and over 135,000 Ugandans acquired the deadly virus last year.
He also expressed concern over the infection rate which has stayed high for a number of years. The national HIV prevalence rate stands at 6.4%.
The 2004-2005 National Sero-Behavioural Survey indicated that people aged between 30 and 40 years were the most infected.
"This could lead to less productivity for the country because this is the the most productive age. It could also mean having many orphans and high poverty levels," Ssekandi said. To light the torch for reviving the battle against AIDS, Ssekandi said Parliament had directed all MPs to advocate HIV prevention, care and treatment in their constituencies.
Parliament also launched the HIV/AIDS policy, which aims at providing peer counselling and drugs to MPs and staff who are living with HIV.
Ssekandi also urged the Government to implement the 2001 Abuja Declaration of African States and increase funding for the health ministry to at least 15% of the national budget.
Since its inception in 1987, TASO has provided care to over 200,000 HIV patients and currently, 23,000 Ugandans depend on it for ARVs, said Robert Ochai, the executive director.
081001
NV081002
Copyright © 2008 - The New Vision. All articles are republished on AEGIS by permission. Material may not be redistributed, posted to any other location, published or used for broadcast without written authorization from Managing Director/Editor-in-chief, The New Vision, P.O. Box 9815, Kampala - Uganda, Tel/fax: 256-41-235221, E-mail: wpike@newvision.co.ug.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .